Dr. Essam Hamza reports

ROCKET DOCTOR AI LAUNCHES A STRATEGIC MARKETING PARTNERSHIP WITH RICK WARE RACING AND FINTEKK AP FOR THE 2026 NASCAR CUP SERIES, NHRA (NATIONAL HOT ROD ASSOCIATION), WORLD SUPERCROSS CHAMPIONSHIP, AFT (AMA - AMERICAN FLAT TRACK) AND OTHER NATIONALLY TELEVISED MOTOR SPORT EVENTS

Rocket Doctor AI Inc. has entered into a definitive marketing agreement with Rick Ware Racing LLC (RWR) and FinTekk AP LLC (FTEK), dated effective June 5, 2026, for the provision of product marketing and brand awareness services, specifically the 2026 NASCAR Cup Series.

The partnership with Rick Ware Racing and FinTekk AP represents a strategic investment in national brand visibility and patient acquisition, supporting the company's efforts to connect more Americans with affordable, physician-led health care services as it continues to expand across the country.

"NASCAR and motorsports offer a powerful platform to connect with passionate, loyal communities across the country, and advance our focus on making health care more accessible, approachable and trusted," said Dr. Essam Hamza, chief executive officer of Rocket Doctor AI. "Through Rick Ware Racing and FinTekk AP, we have an opportunity to introduce Rocket Doctor AI to millions of Americans while expanding our presence in key states, such as California and New York. This partnership further validates the strength of our brand, our technology platform and our vision for the future of health care."

The partnership is designed to accelerate the company's growth through a national marketing, brand awareness and business activation campaign targeting communities that closely align with Rocket Doctor AI's core patient populations, including rural, underserved and working-class populations. Through nationally televised events and integrated media opportunities, Rocket Doctor AI will engage consumers both at live events and through national broadcasts across NBC, FOX, USA Network, Amazon Prime, TNT Sports and HBO Max.

Cody Ware, NASCAR Cup Series driver for Rick Ware Racing, said: "NASCAR fans come from every corner of America, including many rural and underserved communities where access to health care can be a challenge. Having dealt with my own health issues, I understand how important it is to be able to get timely access to care. I'm excited to help introduce Rocket Doctor AI to our fans and be part of a partnership that can make a real difference in fans' lives."

Beyond branding and media exposure, Rick Ware Racing and FinTekk AP will work alongside Rocket Doctor AI to support expansion initiatives in markets hosting major motorsports events, helping the company engage directly with local communities, health care stakeholders, physicians and patients while accelerating awareness of Rocket Doctor AI's health care platform.

About the agreement

The agreement provides for a co-ordinated national brand integrity and awareness, marketing, and business activation campaign designed to support the company's business development and brand rollout in the United States. The campaign is focused on brand awareness in the United States, with primary emphasis on California, New York and the Tri-State area, Texas, and Florida, and will also target international audiences through the motorsport programs.

Under the agreement, the company will be featured as a primary brand, co-primary brand or associated brand on the No. 51 Rick Ware Racing NASCAR Cup Series competition cars across nationally televised events broadcast on NBC, USA Network, Amazon Prime, TNT Sport and HBO Max. The company will also be featured on the No. 51 Rick Ware Racing Top Fuel dragster across nationally televised NHRA events, with featured drivers including eight-time NHRA world champion Tony Schumacher and six-time IHRA world champion Clay Millican. Additional brand placements include the American Flat Track Series with two-time world champion Briar Bauman aboard a Harley-Davidson Flat Track bike, and FIA World Supercross events with three-time AMA champion and current World Supercross rider Cooper Webb.

As consideration for the campaign, the company will issue the marketing partners an aggregate of seven million common shares in the capital of the company at a deemed price of 50 U.S. cents per company share, representing a total value of $3.5-million (U.S.), for services rendered during the period from June 6, 2026, through Sept. 30, 2026. Such company shares will be issued in equal instalments on a monthly basis commencing July 6, 2026, as the campaign is completed and services rendered.

Unless the company delivers written notice to the marketing partners no later than 10 days prior to Sept. 30, 2026, advising of its election to pause the marketing partners' activities, the marketing partners will continue to provide services through Dec. 31, 2026, for which the company will issue an additional three million company shares at a deemed price of 50 U.S. cents per company share, representing an aggregate value of $1.5-million (U.S.), of which 1.5 million company shares will be issued on Nov. 6, 2026, and 1.5 million company shares on Dec. 6, 2026.

Pursuant to the agreement, the marketing partners also hold an option, exercisable upon mutual written consent of all parties, to receive an additional $5-million (U.S.) in company shares (at a deemed price equal to the greater of 50 U.S. cents per company share or a 10-per-cent premium to the current market price) as consideration for a renewal of substantially similar services for the 2027 calendar year.

All company shares issuable pursuant to the agreement will be subject to a contractual lock-up restriction of 12 months from the date of issuance of each monthly tranche.

The campaign commences on June 6, 2026, and continues through Dec. 31, 2026, subject to earlier modification or discontinuance in accordance with its terms and the previously referenced 2027 renewal option.

The marketing partners are arm's length to the company and no finders' fees are payable in connection with the agreement.

Inaugural event

The company and marketing partners currently plan to go live with "all teams" with the associated brand campaign and test as a primary event on June 14 at Pocono, Pa., and then go live in San Diego, Calif., on June 21 on the inaugural Coronado Naval Base Anduril 250 event.

About FinTekk AP LLC

FinTekk is a United States-based corporate finance advisory firm specializing in direct investments, strategic consulting and capital markets solutions. Founded by Kevin P. O'Connell, the firm has been actively investing in and advising companies since the 1990s, with a particular focus on leveraging sports marketing partnerships and brand activation to drive growth for its portfolio companies. FinTekk combines traditional corporate finance expertise with modern revenue activation strategies, helping businesses secure capital, optimize operations and expand their market presence through innovative sponsorships and influencer-driven campaigns.

About Rick Ware Racing LLC

RWR is a multiseries American motorsports team founded in 1995 by former driver and third-generation racer Rick Ware. Headquartered in Mooresville, N.C., the team competes full-time in the NASCAR Cup Series with entries including the No. 51 car driven by Cody Ware. Beyond NASCAR, RWR maintains a diverse racing portfolio that includes the NHRA Mission Foods Drag Racing Series (Top Fuel), Progressive American Flat Track, FIM World Supercross Championship, ARCA Menards Series and other disciplines. With over 40 years in motorsports, Rick Ware has built the organization into a versatile operation known for its entrepreneurial approach, technical alliances (including a new 2026 partnership with Richard Childress Racing and Chevrolet), and success across both four-wheel and two-wheel racing platforms.

About Rocket Doctor AI Inc.

Rocket Doctor AI delivers physician-built, AI-powered (artificial intelligence) solutions designed to make high-quality health care accessible throughout the entire patient journey. A cornerstone of the company's proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.

Alongside the GLM is Rocket Doctor Inc., and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs (medical doctors) to provide care to more than 750,000 patient visits, the company's proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices -- improving efficiency, restoring autonomy to MDs and expanding patient access to care.

By reducing administrative burdens and ensuring greater consistency in care, the company's technology creates more time for meaningful physician-patient interactions. Rocket Doctor AI is committed to reaching underserved, rural and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models and connected medical devices, Rocket Doctor AI is redefining modern health care -- making it more scalable, equitable and patient centred.

We seek Safe Harbor.